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To elucidate the mechanism governing the subcellular distribution of cyclin D1 protein, we ran-
domly mutagenized human cyclin D1 cDNA and isolated mutants that encode the protein predom-
inantly located in the cytoplasm. Experiments with Leptomycin B suggested a defect in
transportation from the cytoplasm to the nucleus rather than enhanced nuclear exportation.
Sequencing revealed that the mutations responsible for the cytoplasmic localization of cyclin D1
resided in the vicinity of the cyclin box, which affected interaction with a catalytic partner, Cdk4.
We propose that interaction between cyclin D1 and Cdk4 triggers the mechanism controlling the
nuclear transportation of this kinase complex.
Structured summary:
MINT-7033488: Cdk4 (uniprotkb:P30285) physically interacts (MI:0218) with Cdk1 (uniprotkb:P25322)
by anti bait coimmunoprecipitation (MI:0006)
MINT-7033511, MINT-7033534: Cdk4 (uniprotkb:P30285) physically interacts (MI:0218) with Cyclin D1
(uniprotkb:P24385) by anti bait coimmunoprecipitation (MI:0006)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The ﬁrst gap (G1) phase of the mammalian cell cycle is an un-
ique period when cells respond to environmental signals to deter-
mine cell fate such as proliferation, differentiation, cellular
senescence, and survival [1]. Important cell cycle regulators, which
govern the progression of the G1 phase, include the D-type cyclin–
Cdk4, Cdk6 protein kinase complexes [2]. The expression of three
D-type cyclins (D1, D2, and D3) ﬂuctuates during the cell cycle
and differs in a tissue-speciﬁc manner, while Cdk4 and Cdk6 are
stably expressed in a cell cycle-independent manner, indicating
that the expression of D-type cyclins is key to the control of cyclin
D-dependent kinase complexes. The expression of cyclin D1, the
major D-type cyclin in ﬁbroblasts, is largely regulated at the tran-
scriptional level by a group of transcriptional activators and
repressors and is triggered by extracellular growth factors, rather
than controlled by the intracellular ‘‘cell cycle clock” mechanism.
In addition to transcriptional control, cyclin D1 is subjected to
additional post-translational regulation associated with its subcel-
lular distribution. With the aid of the Cdk inhibitors p27 and p21
[3], the cyclin D1 in the cytoplasm is bound to Cdk4, and then
transported into the nucleus in an importin-dependent manner.chemical Societies. Published by EThe mechanism of the nuclear transportation remains ill deﬁned
because neither cyclin D1 nor Cdk4 contains a canonical nuclear
localization signal sequence. In the nucleus, the cyclin D1–Cdk4
complex is activated through modiﬁcation by the Cdk-activating
kinase (CAK) [4] and phosphorylates several key substrates, includ-
ing a molecule critical for G1 progression, a retinoblastoma protein
(pRb) [5]. After the entry into S phase, cyclin D1 is phosphorylated
by GSK3b, which triggers its association with CRM1 and nuclear
exportation [6]. In the cytoplasm, phosphorylated cyclin D1 is
ubiquitinated by SCFFbx4 [7], resulting in proteolysis by the
proteasome.
The expression of cyclin D1 was unexpectedly observed in
many growth-arrested cells, such as cardiomyocytes [8], neurons
[9], and hematopoietic stem cells [10]. In such cases, cyclin D1
was frequently detected in the cytoplasm, indicating that the cy-
clin D1 in these cells is functionally inactivated because the major
(and the only physiologically signiﬁcant) substrates for the cyclin
D–Cdk complex are the Rb and Rb-related proteins, which are com-
partmentalized within the nucleus. Thus, besides transcriptional
control, additional ill-deﬁned post-translational mechanisms regu-
late cyclin D–Cdk complexes in mammalian cells. In this study, we
isolated cyclin D1 mutants, which occur in the cytoplasm, from
among a randomly mutagenized cyclin D1 cDNA library and char-
acterized their properties in terms of cell cycle regulation and sub-
cellular distribution.lsevier B.V. All rights reserved.
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2.1. Random mutagenesis by low ﬁdelity PCR and generation of the
mini-library
cDNA corresponding to the entire coding sequence of human
cyclin D1 was ampliﬁed by PCR (35 cycles of 94 C for 1 min,
56 C for 1 min, and 72 C for 1 min) in a low ﬁdelity PCR buffer
containing 0.5 mM MnCl2, twice as much Taq polymerase
(5 units/100 ll), an increased concentration of MgCl2 (ﬁnal concen-
tration, 7 mM), and extra dCTP and dTTP (ﬁnal concentration,
1 mM) in addition to the standard PCR mixture [11] using a pair
of primers speciﬁc to the human cyclin D1 coding sequence (50-
TTC GGA TCC GCC CAT GGA ACA CCA-30 and 50-ATC TAT GCG
GCC GCT CAG AT-30). The resulting DNA fragments were cloned
into the vector pIRES-puro-CAG-GFP in frame with the green ﬂuo-
rescence protein (GFP). The size of the resulting mini-cyclin D1 li-
brary (the number of independent clones) was about 104. We
characterized plasmids derived from several independent colonies
picked randomly from the library, and found that the cloning efﬁ-
ciency (the percentage of clones that contain cDNA) was ca 90%
and the average mutation rate was 100%. (All six clones chosen
from the mini-library contained 1–10 point mutations that con-
tribute to amino acid substitutions. For the detail, see Ref. [11].)
2.2. Cell culture, high efﬁciency transfection, and selection of the cyclin
D1 mutants
NIH3T3 mouse ﬁbroblasts and 293T human embryonic kidney
cells were maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM
glutamine, 100 units/ml of penicillin, and 100 lg/ml of streptomy-
cin (GIBCO/BRL). In some experiments, cells were treated with LMB
(2 ng/ml, puriﬁed and prepared by Yoshida, see Ref. [12]) for 5 h.
Expression vectors were introduced into cells by the modiﬁed cal-
cium phosphate–DNA precipitation method [13,14]. The transfec-
ted cells were selected in the presence of puromycin (5 lg/ml)
for 5 days and the distribution of the GFP-fused mutant cyclin D1
in each independent colony was observed under a ﬂuorescence
microscope. The images were quantitatively analyzed using Image-
quant software. The single cell-derived colonies were expanded
and high molecular weight (HMW) DNA was extracted from each
colony using standard procedures. Mutant human cyclin D1 cDNA
was ampliﬁed by PCR as described above using the HMW DNA as a
template and recloned into the pIRES-puro-CAG-GFP vector in
frame with GFP. Resulting expression vectors were re-screened
as above. We repeated these steps three times and the resulting
cDNAs were puriﬁed and sequenced by the standard protocol.
2.3. Protein analyses
Cell lysis, immunoprecipitation, sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis (SDS–PAGE), and immunoblotting
were performed as described [11,14–16]. Developed ﬁlms were
quantitatively analyzed with a densitograph (ATTO, Japan).Fig. 1. Cytoplasmic distribution of the cyclin D1 mutants. HEK293T (A–D) and
NIH3T3 (E–H) cells were transfected with the pIRES-puro-CAG-GFP expression
vectors containing wild-type (A, B, E, and F) and mutant (mut 1 for C and G, and mut
5 for D and H) cyclin D1 cDNAs, and selected in puromycin for 1 week. GFP-positive
colonies were photographed under the ﬂuorescence microscope. (I) The nuclear (N)
and cytoplasmic (C) signals were quantiﬁed and calculated as the percentages of the
total signal.2.4. Antibodies
Rabbit polyclonal antibodies to GFP and p21 were generated
using bacterially produced polypeptides in our laboratory. Rabbit
polyclonal antibodies to Cdk4 were provided by Dr. Charles J. Sherr.
Rabbit polyclonal antibodies against p27 (C-19), Cdk2 (M2), Cdk4
(C-22), and Grb2 (C-23) and mouse monoclonal antibody to cyclin
D1 (72-13G) were purchased from Santa Cruz Biotechnology.
Mouse monoclonal antibodies to c-tubulin (GTU-88) and an HAepitope (clone 12CA5) were obtained from Sigma and Roche Ap-
plied Science, respectively.
Further details on cell cycle analysis and immunoﬂuorescence
staining are provided as Supplementary data.
3. Results
3.1. Isolation of the cyclin D1 mutants
We randomly mutagenized the entire coding sequence of hu-
man cyclin D1 cDNA by use of the low ﬁdelity PCR method [11]
and generated the cyclin D1 mutant library in the pIRES-puro-
CAG-GFP vector, which allows the expression of GFP-fused cyclin
D1 mutants in mammalian cells under the control of a strong
(CAG) promoter together with the puromycin resistance gene from
the same transcript owing to the IRES sequence. To isolate the cy-
clin D1 mutant by expression screening, we introduced the mutant
cDNA library into the mammalian cell lines, NIH3T3 and HEK293T.
Because the abrupt, strong expression of the wild-type (functional)
cyclin D1 protein in mammalian cells inhibits proliferation [17],
we expected cells expressing mutant cyclin D1 to have a growth
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tion in the presence of puromycin, a number of colonies expressing
the GFP signal were obtained. Among these, we chose those show-
ing the dominantly cytoplasmic GFP signal (data not shown, but
see Fig. 1C and D for example). After expansion of the cells,
HMW DNA was extracted from individual candidate clones, and
the mutant human cyclin D1 cDNA was ampliﬁed by PCR, sub-
cloned into the same vector, introduced into 293T cells, and se-
lected by observation of the cytoplasmic GFP signal.
From three rounds of transfection, we eventually established
several independent 293T-derived cell lines harboring a cytoplas-
mic GFP signal, from which we successfully isolated six cyclin D1
mutant cDNAs (designated mut 1–6, see Fig. 2A). Sequencing re-
vealed that each harbored 10–15 missense point mutations
(Fig. 2A). For further analysis, we chose two mutant cDNAs, mut
1 and mut 5, which exhibited distinctive cytoplasmic signals inFig. 2. Summary of the cytoplasmic cyclin D1 mutants. Positions of the amino acid substi
is summarized on the right of each panel. The cyclin box is shaded with grey. (A) Six indep
mut 1 and its derivatives (mut 1–1 to 1–5). (C) Cytoplasmic mutant mut 5 and its derivboth 293T (Fig. 1C and D, respectively) and NIH3T3 (Fig. 1G and
H, respectively) cells compared to cells transfected with wild-type
cyclin D1 fused with GFP (Fig. 1A, B, E, and F).
3.2. Cytoplasmic cyclin D1 mutants harbor mutations around the
cyclin box domain
To narrow down the site of the mutations responsible for the
cytoplasmic localization, we separated cyclin D1 cDNA into three
pieces by digestion with Pst I and Stu I, and swapped each piece be-
tween the wild-type and mutant cDNAs (Fig. 2B and C). We then
reconstituted the entire coding sequence in the pIRES-puro-CAG-
GFP vector, transfected it onto 293T and NIH3T3 cells, and ob-
served the cells under the ﬂuorescence microscope. For both mut
1 and mut 5, the mutations responsible for cyclin D1’s cytoplasmic
localization resided between the Pst I and Stu I sites. In the case oftution in each cytoplasmic cyclin D1 mutant are shown. The subcellular distribution
endently isolated cytoplasmic cyclin D1 mutants (mut 1–6). (B) Cytoplasmic mutant
atives (mut 5–1 to 5–5).
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rized in the right margin of Fig. 2, and also see Fig. 3 for the mu-
tants 1–3 and 5–3).
To further pinpoint the mutation responsible in mut 5–3, we
generated three independent mutants (L101P, A154T, and A210/
211V) harboring a single point mutation (in the case of 210/211,
two tandem mutations). However, none of the three mutants
showed a cytoplasmic localization (negative data not shown), indi-
cating that two or more point mutations function synergistically.
Furthermore, considering that none of the amino acid substitutions
were shared between the mut 1 and mut 5 mutants, we speculate
that conformational change rather than a single amino acid substi-
tution in this region is important to disrupt the nuclear accumula-
tion of the cyclin D1 protein. Therefore, for further analysis, we used
mutant mut 1–3 and 5–3, both of which exhibited a clear cytoplas-
mic localization (see Fig. 3A and B). The cytoplasmic localization of
the mutants is not due to the fusion with GFP, because we detected
HA-tagged mutant (mut 1–3) protein in the cytoplasm, while wild-
type cyclin D1 was predominantly found in the nucleus (Fig. 3C).Fig. 3. Subcellular distribution of wild-type and cytoplasmic mutant cyclin D1. (A)
NIH3T3 cells were transfected with the pIRES-puro-CAG-GFP expression vectors
containing wild-type and mutant (mut 1–3 and 5–3) cyclin D1 cDNAs. After
selection in puromycin, cells stably expressing GFP-cyclin D1 were isolated and
photographed under the ﬂuorescence microscope. (B) The nuclear (N) and
cytoplasmic (C) signals in panel A were quantiﬁed and calculated as the percentages
of the total signal. (C) NIH3T3 cells were transfected with the expression vectors
encoding HA-tagged wild-type (upper panels) and mutant (mut 1–3, lower panels)
cyclin D1 cDNAs. Cells were ﬁxed, stained with antibody to an HA tag and FITC-
labeled secondary antibody, and photographed under the ﬂuorescent microscopy.
Three independent cells from each transfectant are shown.3.3. The cytoplasmic distribution of the cyclin D1 mutants is not
dependent on nuclear export
During the normal cell cycle, cyclin D1 is excluded from the nu-
cleus after entry into S phase by the nuclear export mechanism.
However, cell cycle analysis of the stable transfectants showed that
the expression of mutant cyclin D1 had little effect on the cell cycle
progression (negative data not shown). Therefore, it is not due to
an increase in the number of cells in the S phase that mutant cyclin
D1 occurs in the cytoplasm.
To investigate further with a more direct approach, we treated
the stable transfectants with an inhibitor of CRM1-dependent nu-
clear export, leptomycin B (LMB) (Fig. 4). GFP-tagged wild-type
cyclin D1 distributed mainly largely in the nucleus though some
was detected in the cytoplasm. LMB treatment diminished the
cytoplasmic but not nuclear signals. In contrast, GFP-mutant cy-
clin D1 (mut 1–3) was located in the cytoplasm in the absence
and presence of LMB, indicating inefﬁcient nuclear transport
rather than enhanced nuclear export.Fig. 4. The cytoplasmic distribution of the cyclin D1 mutant is resistant to LMB. (A)
NIH3T3 cells stably expressing GFP-cyclin D1 (wild-type and cytoplasmic mutant,
mut 1–3) were cultured in the presence (+LMB) and absence (LMB) of LMB and
photographed under the ﬂuorescence microscope. (B) The nuclear (N) and
cytoplasmic (C) signals in panel A were quantiﬁed and calculated as the percentages
of the total signal.
Fig. 5. Stable expression of wild-type and mutant cyclin D1 proteins. The lysates
isolated from NIH3T3 cells stably expressing GFP and GFP-cyclin D1 (wild-type and
cytoplasmic mutants, mut 1–3 and 5–3) were analyzed by immunoblotting with
antibodies speciﬁcally recognizing GFP, Cdk4, and c-tubulin (upper, middle, and
lower panels, respectively).
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complex with the catalytic partner, Cdk4
Because the cytoplasmic cyclin D1 mutants harbored missense
mutations in the vicinity of the cyclin box, we investigated the pos-
sibility that the mutants were unable to interact with the catalytic
partner protein Cdk4. First, the proliferating NIH3T3 cells mock-
transfected or transfected with GFP, GFP-wild–type cyclin D1,
and GFP-mutant cyclin D1 (mut 1-3 and 5-3) were harvested and
analyzed by immunoblotting using antibodies to GFP. Fig. 5 shows
that the GFP-tagged proteins were expressed less extensively than
the parental GFP protein but levels of wild-type and mutant cyclin
D1s were almost the same, and we observed almost undetectable
levels of degradation intermediates. These results indicate that
the GFP signals observed under the ﬂuorescence microscope re-Fig. 6. Cytoplasmic cyclin D1 mutant proteins do not efﬁciently associate with Cdk4 in pr
against Cdk4 (Ry and Rz) from lysates isolated from NIH3T3 cells stably expressing GF
immunoprecipitates were analyzed by immunoblotting with antibodies speciﬁcally rec
panels, respectively). NRS; normal rabbit serum (negative control). The asterisk indicateﬂected the full-length GFP-fused proteins and that the expression
of the cyclin D1 mutants was stably maintained in the proliferating
ﬁbroblasts.
Next, we immunoprecipitated Cdk4 protein from lysates iso-
lated from the proliferating NIH3T3 transfectants and performed
immunoblot analyses using antibodies to cyclin D1 and GFP. Be-
cause our antibody to cyclin D1 is speciﬁc to the mouse protein,
and the GFP-fused protein is of human origin, the endogenous
and ectopically expressed proteins can be distinguished using
these two antibodies [18]. In addition, we used two types of anti-
Cdk4 antibodies, Ry and Rz, the former recognizing all types of
Cdk4 protein while the latter recognizing only the active form of
Cdk4 [18].
Fig. 6 shows that the proliferating NIH3T3 cells contained an ac-
tive cyclin D1–Cdk4 complex (lane 4) and the amount of the com-
plex increased with the ectopic expression of GFP-wild-type cyclin
D1 (lane 8). Because the amount of endogenous cyclin D1 bound to
Cdk4 did not decrease (lanes 7 and 8) although the ectopic GFP-cy-
clin D1 was incorporated in the complex with Cdk4 (lanes 7 and 8),
we speculated that the level of cyclin D1 is the rate limiting factor
in the proliferating NIH3T3 cells and unbound Cdk4 is pooled in
these cells.
In contrast, little mutant cyclin D1 was found in a complex with
Cdk4 (lanes 11, 12, 15, and 16). The endogenous cyclin D1–Cdk4
complex remained unchanged (lanes 11, 12, 15, and 16). Thus,
we conclude that the cytoplasmic cyclin D1 mutants were unable
to associate with the catalytic partner Cdk4 in vivo.
4. Discussion
In this study, we isolated mutant cDNA encoding cyclin D1 pre-
dominantly located in the cytoplasm from a pool of randomly
mutagenized human cyclin D1 cDNAs. Mutant cDNAs contain ami-
no acid substitutions in the vicinity of the so-called ‘‘cyclin box”,
thereby preventing interaction with the catalytic partner Cdk4.
We failed to obtain the mutant with a single amino acid substitu-
tion. This could be because cyclin D binds to its catalytic partner
Cdk using more than one interaction surface, or alternatively, and
most likely, we need to enlarge the size of the mutant library to se-
lect out the single point mutant. Mutations in other areas did not
affect the subcellular distribution. In addition, the cytoplasmic pro-
tein was resistant to the nuclear export inhibitor LMB. Therefore,
we concluded that the cyclin box is important for the nuclear im-
port of cyclin D1, presumably by forming a complex with Cdk4.oliferating cells. Endogenous mouse Cdk4 was immunoprecipitated with antibodies
P and GFP-cyclin D1 (wild-type and cytoplasmic mutants, mut 1–3 and 5–3). The
ognizing Cdk4, mouse cyclin D1 (endo-cycD1), and GFP (upper, middle, and lower
s the position of the immunoglobulin heavy chain.
1580 H. Murakami et al. / FEBS Letters 583 (2009) 1575–1580Although most experiments were performed in the mouse ﬁbro-
blasts with human cDNA, we obtained the same results in human
293T cells, suggesting that the conclusions are common between
species.
In addition to Cdk4, Cdk6 is also a catalytic partner of cyclin D
[2]. The choice of partner remains poorly understood. Furthermore,
cyclin D1 is known to form a complex with Cdk2 and Cdk5 [19]. In
such cases, cyclin D1 is incapable of activating bound Cdks (Cdk2
and Cdk5) [5,20] so the physiological signiﬁcance of this interac-
tion remains to be elucidated. Considering our results, the interac-
tion of inactive Cdk subunits may be required for cyclin Ds to enter
the nucleus, where they may play a role other than in phosphory-
lating their substrates, the Rb family [5,21].
In the case of post-mitotic cardiomyocytes [8] and neurons [9],
cyclin D1 was found to be associated with Cdk4 in the cytoplasm,
showing that the formation of a complex with its catalytic partner
may be required but is not sufﬁcient for transportation into the nu-
cleus. Thus, in addition to nuclear export, the mechanism govern-
ing the selective nuclear import of cyclin D1 needs to be
elucidated, which, in turn, may provide a clue as to how the state
of mammalian cells (most differentiated cells and stem cells in the
adult body) is controlled.
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